02/27/2015 - 10:24am

Camber Pharmaceuticals' latest generic drug launch is used to treat pulmonary hypertension.

02/26/2015 - 12:53pm

Sanofi expands its portfolio of insulin therapy products with the introduction of the once-daily, long-acting Toujeo. 

02/26/2015 - 12:03pm

Greenstone, a subsidiary of Pfizer, announced the introduction of trandolapril/verapamil hydrochloride extended-release tablets to its line of generic pharmaceutical products. 

 

02/26/2015 - 11:43am

The fixed-combination drug Avycaz was granted priority review by the Food and Drug Administration. 

02/24/2015 - 2:41pm

Lupin will bring to market a generic version of Lumigan solution, the company announced. 

02/17/2015 - 9:12am

The Food and Drug Administration has approved Lenvima (lenvatinib) for the treatment of differentiated thyroid cancer. 

02/17/2015 - 8:54am

Teva Pharmaceuticals on Tuesday announced the launch of generic versions of Lovenox (enoxaparin sodium injection) as well as generic Zyvox (linezolid) injection. 

 

02/12/2015 - 12:47pm

Sandoz on Thursday launched telmisartan tablets, the generic version of Micardis from Boehringer Ingelheim. The drug is used to treat hypertension, the company said.

 

02/09/2015 - 1:47pm

Daiichi Sankyo on Monday announced that its Savaysa (edoxaban) tablets are now available in pharmacies across the United States. The drug was granted approval from the Food and Drug Administration on Jan. 8 and is used to reduce the risk of stroke and systemic embolism in patients who have a non-valvular atrial fibrillation, as well as for the treatment of deep vein thrombosis and pulmonary embolism, the company said.